glucagon like peptide 1 glp 1 Glucagon-like in health and disease Glucagon-Like Peptide 1 | C149H226N40O45

Several alternatives can support meaningful weight loss when used with medical guidance

Active Ingredient: Semaglutide Active Ingredient: Tirzepatide Why GLP-1 Therapy May Lead to Fatigue Several factors contribute to the fatigue that some patients experience while taking GLP-1 medications

The 2022 FDA documentation for tirzepatide does not list blood clots as a side effect

Early data also suggest potential benefits in liver disease, obstructive sleep apnea, chronic respiratory disorders, neurodegenerative and psychiatric conditions, reproductive dysfunction, obesity-associated cancers, and sepsis, although these remain investigational

J Ovarian Res 2025